Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kazuo Nakajima

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Microbial Pathogenesis|March 2, 2010
Exclusion of Kif1c as a candidate gene for anthrax toxin susceptibilityKazuo Nakajima, Yosuke Tanaka
The Review of Scientific Instruments|February 4, 2012
One-shot spectrometer for several elements using an integrated conical crystal analyzerKohei Morishita, Kouichi Hayashi, Kazuo Nakajima
Toxicology|June 24, 2004
Chlorpropham induces mitochondrial dysfunction in rat hepatocytesYoshio Nakagawa, Kazuo Nakajima, Toshinari Suzuki
Psychiatry and Clinical Neurosciences|April 13, 2005
Quality of life of schizophrenic patients living in the community: the relationships with personal characteristics, objective indicators and self-esteemHiroko Kunikata, Yoshio Mino, Kazuo Nakajima
[Nihon Koshu Eisei Zasshi] Japanese Journal of Public Health|June 10, 2006
[Factors affecting WHOQOL-26 in community-dwelling patients with schizophrenia]Hiroko Kunikata, Yoshio Mino, Kazuo Nakajima
Scientific Reports|April 24, 2025
Author Correction: Utility of a commercial antibody against NTRK1 for western blotting and potential application to immunohistochemistry in adult mouse brainKazuo Nakajima, Mizuho Ishiwata, Tadafumi Kato
Psychiatry and Clinical Neurosciences|July 6, 2016
Effect of cognitive behavioral group therapy for recovery of self-esteem on community-living individuals with mental illness: Non-randomized controlled trialHiroko Kunikata, Naoki Yoshinaga, Kazuo Nakajima
Scientific Reports|February 15, 2025
Utility of a commercial antibody against NTRK1 for western blotting and potential application to immunohistochemistry in adult mouse brainKazuo Nakajima, Mizuho Ishiwata, Tadafumi Kato
The Review of Scientific Instruments|April 2, 2008
Wave-dispersive x-ray spectrometer for simultaneous acquisition of several characteristic lines based on strongly and accurately shaped Ge crystalKouichi Hayashi, Kazuo Nakajima, Kozo Fujiwara, et al.
Nursing & Health Sciences|February 27, 2003
Development of the chronic obstructive pulmonary disease activity rating scale: reliability, validity and factorial structureMichiko Morimoto, Kenichi Takai, Kazuo Nakajima, et al.
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Microbial Pathogenesis|March 2, 2010
Exclusion of Kif1c as a candidate gene for anthrax toxin susceptibilityKazuo Nakajima, Yosuke Tanaka
The Review of Scientific Instruments|February 4, 2012
One-shot spectrometer for several elements using an integrated conical crystal analyzerKohei Morishita, Kouichi Hayashi, Kazuo Nakajima
Toxicology|June 24, 2004
Chlorpropham induces mitochondrial dysfunction in rat hepatocytesYoshio Nakagawa, Kazuo Nakajima, Toshinari Suzuki
Psychiatry and Clinical Neurosciences|April 13, 2005
Quality of life of schizophrenic patients living in the community: the relationships with personal characteristics, objective indicators and self-esteemHiroko Kunikata, Yoshio Mino, Kazuo Nakajima
[Nihon Koshu Eisei Zasshi] Japanese Journal of Public Health|June 10, 2006
[Factors affecting WHOQOL-26 in community-dwelling patients with schizophrenia]Hiroko Kunikata, Yoshio Mino, Kazuo Nakajima
Scientific Reports|April 24, 2025
Author Correction: Utility of a commercial antibody against NTRK1 for western blotting and potential application to immunohistochemistry in adult mouse brainKazuo Nakajima, Mizuho Ishiwata, Tadafumi Kato
Psychiatry and Clinical Neurosciences|July 6, 2016
Effect of cognitive behavioral group therapy for recovery of self-esteem on community-living individuals with mental illness: Non-randomized controlled trialHiroko Kunikata, Naoki Yoshinaga, Kazuo Nakajima
Scientific Reports|February 15, 2025
Utility of a commercial antibody against NTRK1 for western blotting and potential application to immunohistochemistry in adult mouse brainKazuo Nakajima, Mizuho Ishiwata, Tadafumi Kato
The Review of Scientific Instruments|April 2, 2008
Wave-dispersive x-ray spectrometer for simultaneous acquisition of several characteristic lines based on strongly and accurately shaped Ge crystalKouichi Hayashi, Kazuo Nakajima, Kozo Fujiwara, et al.
Nursing & Health Sciences|February 27, 2003
Development of the chronic obstructive pulmonary disease activity rating scale: reliability, validity and factorial structureMichiko Morimoto, Kenichi Takai, Kazuo Nakajima, et al.
Pageof 5